Drug plasma levels and coronary vasodilation after isosorbide dinitrate chewing capsules
Open Access
- 1 November 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 10 (suppl F) , 137-141
- https://doi.org/10.1093/eurheartj/10.suppl_f.137
Abstract
Five, ten and fifteen min after sublingual administration of 10 mg isosorbide dinitrate (ISDN) in chewing capsules, in 10 patients with coronary artery disease, ISDN plasma levels were correlated with the dilation of epicardial coronary arteries as well as with changes in aortic blood pressure and heart rate. Due to the rapid and extensive drug absorption, maximal ISDN plasma levels averaged 138±73ng ml−1 and were already obtained after 5 min; they declined to 102±76and 602±34ng ml−1 in the 10th and 15th min respectively. In 7 patients isosorbide mononitrate plasma levels were still negligibly low (−1). Mean diameters of ‘normal’ coronary segments increased by an average of 20±10%, 26±11% and 27±13% (P−1; P<0·01) were observed in the 15th min; diastolic aortic pressure and double product remained constant. Due to the long persistence of coronary dilation andhaemodynamic changes, none of these drug effects correlated significantly with the ISDN plasma levels. In addition, the minimal diameters of 10 coronary stenoses were measured in 7 patients; with ISDN 7 stenoses showed dilation ranging from 23% to 98%. ISDN chewing capsules can be suitable for the immediate relief of anginal attacks as well as for rapid, potent and prolonged coronary dilation during coronary angiography.Keywords
This publication has 0 references indexed in Scilit: